Progressive Care Inc (OTCMKTS:RXMD) saw a high of $0.0125 from the opening of $0.0085. On Augusts 6th, OTCMKTS:RXMD hit a high of $0.0144. Investors are happy to see green numbers again since from August 6th to August 12th, the stock has dropped around 40%. As of 4:00 am, RXMD closed at $0.01 and is traded with a volume of 21,750,000. A recent 3 cent price target was placed on the stock by an independent analyst. This can be viewed here: http://bit.ly/RXMD_Analyst_Report

Oxis International Inc (OTCMKTS:OXIS) was at $0.0179 as of 11:35 AM on August 12th. At that same time, it was down 0.56% and the volume was at 666,242. The HOD, also at the same time, was $0.02. Just a few days before, on Monday, August 10th, OTCMKTS:OXIS saw a high $0.027. Since then, it fell 33.7% to Wednesday’s price. On August 12th, at 11:01 AM, an analyst coverage was released on the stock, keeping investors informed. An analyst report put out by Taurus Investment Research put a $0.04 price target on the stock and gave it an overall “Buy” rating. That report can be found here: http://bit.ly/OXIS_Analyst_Report

Ceres Inc (NASDAQ:CERE) had an amazing opening on Wednesday, August 12th. As of 11:45 AM, NASDAQ:CERE was up 187.58% at $2.7395. As of 11:50 AM, the stock hit a high of $4.80 which is 403% up from the previous close of $0.9526. That same morning, CERE had a press release stating that they received a patent a multi-gene trait development system for crops. This is a key milestone for the company and its future of, as they hope, more developments.

Eleven Biotherapeutics Inc (NASDAQ:EBIO) also had a great opening on Wednesday, August 12th. As of 11:54 AM, NASDAQ:EBIO was up 81.62% at $4.25. At that same time, EBIO hit a high of $8.00 which is 241% up from the previous close of $2.34. The stock was trading at 11:55 AM with a volume of 6,087,092. EBIO also had a press release that morning. They officially had their first patients dosed with EBI-005 in a Phase 3 study. EBIO looks to be making moves, and will continue to do so in the future.

Get the Inside Scoop On CERE here with this Free Report

At May 31, 2014, cash and cash equivalents and marketable securities totaled $32.5 million.

China Recycling Energy Corporation (NASDAQ:CREG)’s shares climbed 14.01% to $1.79. The company on July 11 announced that it has entered into a Standby Equity Distribution Agreement (“SEDA”) with YA Global Master SPV Ltd. (“YA Global”), a Cayman Islands exempt limited partnership on July 8, 2014. Under the terms of the agreement, YA Global is committed to purchase up to US$50 million of the Company’s common stock over a period of 2 years following the effectiveness of the registration statement registering the resale of shares purchased by YA Global. The Company may in its discretion draw on the facility from time to time by delivering an advance notice to YA Global.

You won’t believe what we found out about CREG

Progenics Pharmaceuticals, Inc.(NASDAQ:PGNX)’s shares increased 16.74% to $4.95. Salix Pharmaceuticals, Ltd. (SLXP) and Progenics Pharmaceuticals (PGNX) on July 14 announced that the Food and Drug Administration (FDA or Agency) has informed Salix that RELISTOR® (methylnaltrexone bromide) Subcutaneous Injection, 20 mg/ml, for the treatment of opioid-induced constipation (OIC) in patients taking opioids for chronic non-cancer pain can be approved on the data submitted in the sNDA. The FDA Office of Drug Evaluation III responded to the Company’s formal appeal filed in response to the Complete Response Letter (CRL) of July 27, 2012 to the supplemental NDA (sNDA) for RELISTOR. The Agency’s letter stated that, “Salix’s request that FDA approve the supplemental NDA for RELISTOR subcutaneous injection for the treatment of opioid-induced constipation in patients with chronic non-cancer pain based on the submitted data is granted.”

Why Should You Buy PGNX Now? Get The Free Trend Analysis Here